Pacific Shuanglin Bio-Pharmacy Co.,Ltd.’s Net Profit Dropped 47% in First Quarter of 2023

Pacific Shuanglin Bio-Pharmacy Co.,Ltd. (派斯双林生物制药股份有限公司) (000403.SZ) reported a net profit of 56.2 million yuan in the first quarter of 2023, down 47% year-on-year.

Meanwhile, the company posted 260.9 million yuan in revenue, down 47.9% year-on-year.

At the end of the reporting period, it had 7.9 billion yuan in total assets and 1 billion yuan in total liabilities, with a liability-to-asset ratio of 12.6%.